Levoleucovorin: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Levoleucovorin. Educational only — not medical advice.

Labeled uses

KHAPZORY is indicated for: rescue after high-dose methotrexate therapy in adult and pediatric patients with osteosarcoma. diminishing the toxicity associated with overdosage of folic acid antagonists or impaired methotrexate elimination adult and pediatric patients. The treatment of adults with metastatic colorectal cancer in combination with fluorouracil. Limitations of Use KHAPZORY is not indicated for pernicious anemia and megaloblastic anemia secondary to lack the of vitamin B12 because of the risk of progression of neurologic manifestations despite hematologic remission.

Source: FDA labeling via NIH DailyMed (set 344f65ac…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.